Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The lipoprotein-associated coagulation inhibitor.

G J Broze, T J Girard, W F Novotny

    Progress in Hemostasis and Thrombosis
    |January 1, 1991
    PubMed
    Summary

    Lipoprotein-associated coagulation inhibitor (LACI) regulates blood coagulation by inhibiting the TF-VIIa complex. This novel feedback mechanism explains hemostasis and thrombosis, though its in vivo role requires further research.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Suppressing protein Z-dependent inhibition of factor Xa improves coagulation in hemophilia A.

    Journal of thrombosis and haemostasis : JTH·2018
    Same author

    Re-evaluation of mouse tissue factor pathway inhibitor and comparison of mouse and human tissue factor pathway inhibitor physiology.

    Journal of thrombosis and haemostasis : JTH·2018
    Same author

    Evidence of clinically significant extravascular stores of factor IX.

    Journal of thrombosis and haemostasis : JTH·2013
    Same author

    Protein Z, protein Z-dependent protease inhibitor (serpinA10), and the acute-phase response.

    Journal of thrombosis and haemostasis : JTH·2012
    Same author

    The C-terminus of tissue factor pathway inhibitor α is required for its interaction with factors V and Va.

    Journal of thrombosis and haemostasis : JTH·2012
    Same author

    Tissue factor pathway inhibitor endocytosis.

    Trends in cardiovascular medicine·2011

    Area of Science:

    • Biochemistry
    • Hematology
    • Molecular Biology

    Background:

    • Tissue factor (TF) initiates coagulation, crucial for hemostasis and thrombosis.
    • Lipoprotein-associated coagulation inhibitor (LACI) was identified as a key regulator.
    • LACI's mechanism of action was recently elucidated.

    Purpose of the Study:

    • To define the mechanism of action of LACI in regulating coagulation.
    • To understand the role of LACI in hemostasis and thrombosis.
    • To explore the implications of LACI in explaining coagulation pathways.

    Main Methods:

    • Characterization of LACI's inhibitory mechanism.
    • In vitro studies of LACI's interaction with factor Xa (FXa) and the TF-VIIa complex.
    • Analysis of LACI's role in protease cascade feedback inhibition.

    Main Results:

    • LACI inhibits the TF-VIIa catalytic complex in a factor Xa-dependent manner.
    • LACI acts as a multi-headed protease inhibitor, binding FXa and then interacting with factor VIIa.
    • This novel feedback inhibition mechanism is unique to protease cascades.

    Conclusions:

    • LACI's mechanism explains the necessity for both extrinsic and intrinsic coagulation pathways.
    • TF initiates a burst of FXa generation for initial hemostasis, while intrinsic pathways ensure persistent coagulation.
    • Further research is needed to confirm LACI's in vivo significance and elucidate remaining questions about its function and interactions.

    Related Experiment Videos